Silverback Therapeutics Company

Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways. They are developing a new generation of systemically delivered, locally active therapies that potently modulate fundamental disease pathways once deemed inaccessible.
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States

Visit Website
Register and Claim Ownership